2024 Cardiology Symposium

2024 Cardiology Symposium is organized by Billings Clinic and will be held on Feb 16, 2024 at Billings clinic, Billings, Montana, United States of America.

Overview:
Through a series of interactive lectures, in-person and virtual learners will deepen their understanding regarding the large spectrum of disease states in multiple cardiovascular subspecialties. The cardiology symposium will review basic principles and add new updates to treatment. Topics include simple and complex EKG interpretation, treatment of ST elevation MI in rural facilities, therapies for treatment and diagnosis of structural heart disease, peripheral vascular disease, and advanced heart failure.  Discussion of electrophysiology including atrial fibrillation and devices will also be included.

Objectives:
• Describe 12 lead interpretation of axis deviations that could indicate fascicular blocks. Given a 12 lead, determine the presence of Bundle Branch Block. Define and describe the clinical significance of a bifascicular block and discuss various strategies in managing a bifascicular block.
• Discuss the changes relating to the 2010 and 2015 Tachycardia Guidelines. Describe the limitations of lead II monitoring and the benefits of a 12 lead. Describe the three things needed to be ready for tachycardia and the five criteria for proving VT on a 12 Lead ECG. Given a new tachycardia algorithm, use the information to discuss treatment options.
• Review the epidemiology, classification, and implication of peripheral vascular disease. Identify the common complaints to suspect peripheral vascular disease. Discuss screening tests to identify peripheral vascular disease and what procedures can be performed for treatment.
• Identify what will constitute the “Last Pandemic in Cardiovascular Disease,” and why it may kill 10X more humans than COVID-19. Discuss noninvasive screening testing for catching carotid brain artery, coronary artery, and lower extremity peripheral arterial disease before it can hurt patients or lead to limb loss. Discuss how vascular bypass surgery is being replaced by new outpatient “endovascular” procedures that can be performed through the wrist and foot arteries.
• Define Structural Heart Disease and Structural Cardiology. Discuss how to identify patients who can benefit from transcatheter therapies and when to refer. Review how to identify hospitalized patients that can benefit from acute interventions when surgery is not an option.
• Describe the different types of CIEDs used commonly in clinic practice. Describe basic indications for pacemakers and defibrillators. Understand basic programming settings for cardiac pacemakers.
• Discuss the incidence and pathophysiology of atrial fibrillation.Discuss stroke mitigation strategies. Discuss the importance of risk factor modification.
• Recognize risk factors for Acute MI mortality. Review unique challenges of MI treatment in Montana. Discuss treatment of acute MI for critical access hospitals.
• Review current strategies of pharmaceuticals in heart failure treatment. Review current mechanical strategies in heart failure treatment. Review when to refer for a higher level of care.
• Define cardiogenic shock and how to correctly identify it. Discuss different phenotypes of cardiogenic shock. Review pharmacological and temporary mechanical circulatory support options for cardiogenic shock.